Mogamulizumab
From IDWiki
- Monoclonal antibody that targets CC chemokine receptor 4 (CCR4)
- Indicated for treatment of certain T cell lymphomas, including mycosis fungoides and Sézary syndrome
- May be associated with hepatitis B and CMV reactivation
